Beirong Biogenetic Engineering

Beijing Beirong Biogenetic Engineering is a Chinese biotechnology company specialized in the development and manufacturing of recombinant protein therapeutics. Established in 1994, the company is recognized as one of the pioneer domestic producers of recombinant human growth hormone (rhGH) in China. Its flagship product is used to treat various growth-related disorders, including pediatric growth hormone deficiency and Turner syndrome. The company operates as a key subsidiary within a larger pharmaceutical group, focusing on the endocrinology market. Beirong Biogenetic Engineering maintains a strong manufacturing presence in Beijing, adhering to domestic GMP standards for biologics production.